- Home
- OPRX vs CVRX Comparison
OPRX vs CVRX Comparison
Compare OPRX & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- CVRX
- Stock Information
- Founded
- OPRX 2006
- CVRX 2000
- Country
- OPRX United States
- CVRX United States
- Employees
- OPRX N/A
- CVRX N/A
- Industry
- OPRX Business Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OPRX Consumer Discretionary
- CVRX Health Care
- Exchange
- OPRX Nasdaq
- CVRX Nasdaq
- Market Cap
- OPRX 234.9M
- CVRX 189.0M
- IPO Year
- OPRX N/A
- CVRX 2021
- Fundamental
- Price
- OPRX $17.25
- CVRX $7.80
- Analyst Decision
- OPRX Buy
- CVRX Buy
- Analyst Count
- OPRX 8
- CVRX 7
- Target Price
- OPRX $11.81
- CVRX $14.00
- AVG Volume (30 Days)
- OPRX 436.8K
- CVRX 309.8K
- Earning Date
- OPRX 08-07-2025
- CVRX 08-04-2025
- Dividend Yield
- OPRX N/A
- CVRX N/A
- EPS Growth
- OPRX N/A
- CVRX N/A
- EPS
- OPRX N/A
- CVRX N/A
- Revenue
- OPRX $104,748,000.00
- CVRX $54,652,000.00
- Revenue This Year
- OPRX $14.44
- CVRX $11.32
- Revenue Next Year
- OPRX $10.63
- CVRX $18.58
- P/E Ratio
- OPRX N/A
- CVRX N/A
- Revenue Growth
- OPRX 25.89
- CVRX 23.11
- 52 Week Low
- OPRX $3.78
- CVRX $4.30
- 52 Week High
- OPRX $18.22
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- OPRX 62.81
- CVRX 56.11
- Support Level
- OPRX $15.10
- CVRX $7.08
- Resistance Level
- OPRX $17.73
- CVRX $7.79
- Average True Range (ATR)
- OPRX 1.29
- CVRX 0.56
- MACD
- OPRX 0.11
- CVRX -0.00
- Stochastic Oscillator
- OPRX 84.30
- CVRX 96.49
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.